Clinical and Virologic Response to Episodic Acyclovir for Genital Ulcers Among HIV-1 Seronegative, Herpes Simplex Virus Type 2 Seropositive African Women: A Randomized, Placebo-Controlled Trial

被引：6

作者：

Baeten, Jared M. ^{[1
,2
,3
]}

Reid, Stewart E. ^{[4
,5
]}

Delany-Moretlwe, Sinead ^{[6
]}

Hughes, James P. ^{[7
]}

Wang, Richard S. ^{[1
]}

Wilcox, Ellen ^{[1
]}

Limbada, Mohammed ^{[5
]}

Akpomiemie, Godspower ^{[6
]}

Corey, Lawrence ^{[2
,8
,9
]}

Wald, Anna ^{[2
,3
,8
,9
]}

Celum, Connie ^{[1
,2
,3
]}

机构：

[1] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA

[2] Univ Washington, Dept Med, Seattle, WA 98104 USA

[3] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA

[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

[5] Ctr Infect Dis Res Zambia, Lusaka, Zambia

[6] Univ Witwatersrand, Sch Clin Med, Wits Inst Reprod Hlth & HIV, Johannesburg, South Africa

[7] Univ Washington, Dept Biostat, Seattle, WA 98104 USA

[8] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA

[9] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA

来源：

SEXUALLY TRANSMITTED DISEASES | 2012年 / 39卷 / 01期

基金：

美国国家卫生研究院;

关键词：

ORAL ACYCLOVIR; DOUBLE-BLIND; SUPPRESSION; MEN; VALACYCLOVIR; ACQUISITION; INFECTION; EFFICACY; IMPACT; RNA;

D O I：

10.1097/OLQ.0b013e31823b50c6

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In a randomized trial among African women with recurrent genital herpes, episodic acyclovir therapy resulted in modestly greater likelihood of lesion healing (hazard ratio [HR] = 1.48, P = 0.098; mean, 5.1 vs. 6.0 days) and cessation of herpes simplex virus shedding (HR = 1.88, P = 0.008; mean, 3.0 vs. 5.0 days) compared with placebo, similar to results of studies in high-income countries (ClinicalTrials.gov registration NCT00808405).

引用

页码：21 / 24

页数：4

共 43 条

[31] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN VACCINE IN PERSONS AT HIGH-RISK FOR GENITAL HERPES INFECTION
MERTZ, GJ
ASHLEY, R
BURKE, RL
BENEDETTI, J
CRITCHLOW, C
JONES, CC
COREY, L
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04): : 653 - 660
[32] Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial
Reynolds, Steven J.
Makumbi, Fred
Newell, Kevin
Kiwanuka, Noah
Ssebbowa, Paschal
Mondo, George
Boaz, Iga
Wawer, Maria J.
Gray, Ronald H.
Serwadda, David
Quinn, Thomas C.
LANCET INFECTIOUS DISEASES, 2012, 12 (06): : 441 - 448
[33] Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial
Van Wagoner, Nicholas
Fife, Kenneth
Leone, Peter A.
Bernstein, David I.
Warren, Terri
Panther, Lori
Novak, Richard M.
Beigi, Richard
Kriesel, John
Tyring, Stephen
Koltun, William
Lucksinger, Gregg
Morris, Amy
Zhang, Bin
McNeil, Lisa K.
Tasker, Sybil
Hetherington, Seth
Wald, Anna
JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (12): : 1890 - 1899
[34] A randomized placebo-controlled trial of the impact of multiple micronutrient supplementation on HIV-1 genital shedding among Thai subjects (vol 37, pg 1216, 2004)
Jiamto, S
Chaisilwattana, P
Pepin, J
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (02) : 240 - 240
[35] HIV-1 and herpes simplex virus type-2 genital shedding among co-infected women using self-collected swabs in Chiang Rai, Thailand
Forhan, S. E.
Dunne, E. F.
Sternberg, M. R.
Whitehead, S. J.
Leelawiwat, W.
Thepamnuay, S.
Chen, C.
Evans-Strickfaden, T. T.
McNichol, J. M.
Markowitz, L. E.
INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (08) : 560 - 564
[36] Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa
Ghebremichael M.
Habtzgi D.
Paintsil E.
BMC Research Notes, 5 (1)
[37] Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
Mugo, Nelly R.
Stalter, Randy M.
Heffron, Renee
Rees, Helen
Scoville, Caitlin W.
Morrison, Charles
Kourtis, Athena P.
Bukusi, Elizabeth
Beksinka, Mags
Philip, Neena M.
Beesham, Ivana
Deese, Jen
Edward, Vinodh
Donnell, Deborah
Baeten, Jared M.
CLINICAL INFECTIOUS DISEASES, 2022, 75 (04) : 586 - 595
[38] Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study
Low, Andrea J.
Nagot, Nicolas
Weiss, Helen A.
Konate, Issouf
Kania, Dramane
Segondy, Michel
Meda, Nicolas
van de Perre, Philippe
Mayaud, Philippe
JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (05): : 731 - 737
[39] Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, doubleblind, placebo-controlled, phase 2b trial
Gray, Glenda E.
Mngadi, Kathryn
Lavreys, Ludo
Nijs, Steven
Gilbert, Peter B.
Hural, John
Hyrien, Ollivier
Juraska, Michal
Luedtke, Alex
Mann, Philipp
Mcelrath, M. Juliana
Odhiambo, Jackline A.
Stieh, Daniel J.
van Duijn, Janine
Takalani, Azwidihwi N.
Willems, Wouter
Tapley, Asa
Tomaras, Georgia D.
Van Hoof, Johan
Schuitemaker, Hanneke
Swann, Edith
Barouch, Dan H.
Kublin, James G.
Corey, Lawrence
Pau, Maria G.
Buchbinder, Susan
Tomaka, Frank
LANCET INFECTIOUS DISEASES, 2024, 24 (11): : 1201 - 1212
[40] Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-Uninfected Men and Women A Subgroup Analysis of a Randomized Trial
Celum, Connie
Morrow, Rhoda A.
Donnell, Deborah
Hong, Ting
Hendrix, Craig W.
Thomas, Katherine K.
Fife, Kenneth H.
Nakku-Joloba, Edith
Mujugira, Andrew
Baeten, Jared M.
ANNALS OF INTERNAL MEDICINE, 2014, 161 (01) : 11 - +

← 1 2 3 4 5 →